| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research &Development | Director
3 companies
Malik Fady Ibraham is an EVP Research &Development at CYTOKINETICS INC with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $11.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $55.90 | $408,103.00 | -2.7% | +1.1% | -33.2% | |
| Jun 25, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,300 | $53.72 | $392,143.00 | -2.7% | -1.5% | -37.4% | |
| Jun 11, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 7,788 | $53.04 | $413,106.08 | -2.8% | +4.8% | -37.9% | |
| May 7, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 15,547 | $65.11 | $1,012,265.17 | -5.3% | -18.2% | -49.4% | |
| Apr 9, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 32,605 | $74.31 | $2,422,917.55 | -10.4% | -24.5% | -50.3% | |
| Mar 5, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 32,604 | $67.56 | $2,202,606.24 | -10.5% | -24.9% | -33.9% | |
| Feb 6, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 32,605 | $79.30 | $2,585,496.50 | -10.1% | -18.8% | -37.1% | |
| Jan 4, 2024 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 15,678 | $86.98 | $1,363,712.44 | -5.0% | -19.6% | -44.1% | |
| Nov 9, 2023 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,500 | $35.40 | $88,500.00 | -1.6% | +132.9% | +75.1% | |
| Oct 12, 2023 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,500 | $35.89 | $89,725.00 | -1.6% | +204.4% | +64.4% |